163 related articles for article (PubMed ID: 3921279)
1. Dose requirements and hemodynamic effects of transdermal nitroglycerin compared with placebo in patients with congestive heart failure.
Jordan RA; Seith L; Henry DA; Wilen MM; Franciosa JA
Circulation; 1985 May; 71(5):980-6. PubMed ID: 3921279
[TBL] [Abstract][Full Text] [Related]
2. Hemodynamic and hormonal effects of high-dose transdermal nitroglycerin in patients with chronic congestive heart failure.
Elkayam U; Roth A; Henriquez B; Weber L; Tonnemacher D; Rahimtoola SH
Am J Cardiol; 1985 Sep; 56(8):555-9. PubMed ID: 3929585
[TBL] [Abstract][Full Text] [Related]
3. Rapidly developing tolerance to transdermal nitroglycerin in congestive heart failure.
Jordan RA; Seth L; Casebolt P; Hayes MJ; Wilen MM; Franciosa J
Ann Intern Med; 1986 Mar; 104(3):295-8. PubMed ID: 3080935
[TBL] [Abstract][Full Text] [Related]
4. Sustained beneficial hemodynamic effects of low transdermal nitroglycerin doses compared with placebo in patients with congestive heart failure.
Bolognese L; Sarasso G; Rognoni G; Makmur J; Fornaro G; Perucca A; Rossi P
Clin Cardiol; 1988 Feb; 11(2):79-85. PubMed ID: 3126012
[TBL] [Abstract][Full Text] [Related]
5. Comparative hemodynamic effects of chewable isosorbide dinitrate and nitroglycerin in patients with congestive heart failure.
Mikulic E; Franciosa JA; Cohn JN
Circulation; 1975 Sep; 52(3):477-82. PubMed ID: 808359
[TBL] [Abstract][Full Text] [Related]
6. Sustained beneficial hemodynamic responses to large doses of transdermal nitroglycerin in congestive heart failure and comparison with intravenous nitroglycerin.
Rajfer SI; Demma FJ; Goldberg LI
Am J Cardiol; 1984 Jul; 54(1):120-5. PubMed ID: 6430054
[TBL] [Abstract][Full Text] [Related]
7. Nitroglycerin in a transdermal therapeutic system in chronic heart failure.
Sharpe DN; Coxon R
J Cardiovasc Pharmacol; 1984; 6(1):76-82. PubMed ID: 6199616
[TBL] [Abstract][Full Text] [Related]
8. Combined hemodynamic effects of nifedipine and nitroglycerin in congestive heart failure.
Kubo SH; Fox SC; Prida XE; Cody RJ
Am Heart J; 1985 Nov; 110(5):1032-4. PubMed ID: 3933315
[TBL] [Abstract][Full Text] [Related]
9. Early tolerance to hemodynamic effects of high dose transdermal nitroglycerin in responders with severe chronic heart failure.
Roth A; Kulick D; Freidenberger L; Hong R; Rahimtoola SH; Elkayam U
J Am Coll Cardiol; 1987 Apr; 9(4):858-64. PubMed ID: 3104435
[TBL] [Abstract][Full Text] [Related]
10. [The acute, chronic continuous after treatment and chronic intermittent with a variable therapeutic window (4 and 6 hours) hemodynamic effects induced with transdermal nitroglycerin in patients with congestive heart failure].
Nodari S; Metra M; Gei P; Danesi R; Furloni R; Cuminetti S; Dei Cas L
Cardiologia; 1991 Jun; 36(6):451-60. PubMed ID: 1769029
[TBL] [Abstract][Full Text] [Related]
11. Prevention of tolerance to hemodynamic effects of nitrates with concomitant use of hydralazine in patients with chronic heart failure.
Gogia H; Mehra A; Parikh S; Raman M; Ajit-Uppal J; Johnson JV; Elkayam U
J Am Coll Cardiol; 1995 Dec; 26(7):1575-80. PubMed ID: 7594088
[TBL] [Abstract][Full Text] [Related]
12. Hemodynamic factors limiting the response to transdermal nitroglycerin in severe chronic congestive heart failure.
Packer M; Medina N; Yushak M; Lee WH
Am J Cardiol; 1986 Feb; 57(4):260-7. PubMed ID: 3080861
[TBL] [Abstract][Full Text] [Related]
13. Hemodynamic and renal excretory effects of human brain natriuretic peptide infusion in patients with congestive heart failure. A double-blind, placebo-controlled, randomized crossover trial.
Marcus LS; Hart D; Packer M; Yushak M; Medina N; Danziger RS; Heitjan DF; Katz SD
Circulation; 1996 Dec; 94(12):3184-9. PubMed ID: 8989127
[TBL] [Abstract][Full Text] [Related]
14. Multicenter studies of 2% nitroglycerin ointment in patients with heart failure.
Kawai C; Kambara H; Nakano T; Hirota Y; Saito M; Kagoshima T; Nobuyoshi M; Tsuruha Y
Clin Ther; 1984; 6(5):677-88. PubMed ID: 6434184
[TBL] [Abstract][Full Text] [Related]
15. [8-hour hemodynamic study of 2 sustained-release nitrate derivatives. Comparative double-blind study against placebo].
Dubourg O; Guéret P; Ferrier A; Léger P; Farcot JC; Rigaud M; Beaumont D; Bardet J; Bourdarias JP
Arch Mal Coeur Vaiss; 1983 Feb; 76(2):211-9. PubMed ID: 6407429
[TBL] [Abstract][Full Text] [Related]
16. The effect of hydralazine on the development of tolerance to continuous nitroglycerin.
Parker JD; Parker AB; Farrell B; Parker JO
J Pharmacol Exp Ther; 1997 Feb; 280(2):866-75. PubMed ID: 9023301
[TBL] [Abstract][Full Text] [Related]
17. Incidence of early tolerance to hemodynamic effects of continuous infusion of nitroglycerin in patients with coronary artery disease and heart failure.
Elkayam U; Kulick D; McIntosh N; Roth A; Hsueh W; Rahimtoola SH
Circulation; 1987 Sep; 76(3):577-84. PubMed ID: 3113764
[TBL] [Abstract][Full Text] [Related]
18. Interaction of intravenous atrial natriuretic factor with furosemide in patients with heart failure.
Connelly TP; Francis GS; Williams KJ; Beltran AM; Cohn JN
Am Heart J; 1994 Feb; 127(2):392-9. PubMed ID: 8296708
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic-hemodynamic studies of transdermal nitroglycerin in congestive heart failure.
Armstrong PW
J Am Coll Cardiol; 1987 Feb; 9(2):420-5. PubMed ID: 3100600
[TBL] [Abstract][Full Text] [Related]
20. [Hemodynamic effect and duration of action of Deponit 10 in patients with congestive heart insufficiency].
Vogt A; Kreuzer H
Z Kardiol; 1986; 75 Suppl 3():86-9. PubMed ID: 3099488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
